Here are relevant reports on : stylus-pen-market
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
Barrier Materials Market by Type (PVDC, EVOH, PEN and Others), by End-Use Industry (Food & Beverage, Pharmaceutical, Cosmetic, Agriculture, and Others) - Global Forecast to 2020
Barrier materials are categorized into varied types, such as PVDC, EVOH, and PEN, based on their functionalities. They possess inherent properties, such as high durability, strong impact and thermal, and chemical resistances. Barrier Materials: The global barrier materials market was valued at USD 1.74 Billion in 2014 and is expected to reach USD 2.64 Billion by 2020, at a CAGR of 7.26%, between 2015 and 2020
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Cognitive Assessment and Training in Healthcare Market by Assessment Type (Pen-and-Paper Based, Hosted, and Biometrics), Components, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), & Region - Global forecast to 2021
Cognitive impairment can occur in early childhood or late adulthood. There are various reasons for it, which can be reversible or irreversible. Early causes may include malnutrition, prenatal drug exposure, genetic syndromes, and chromosome abnormalities. The brain retains its neuroplasticity till late adulthood; therefore, there has been a growing demand for cognitive assessment and training. MarketsandMarkets predicts the global cognitive assessment and training in healthcare market to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. The year 2015 has been considered as the base year, while the forecast period is 2016–2021.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Counterfeit Money Detection Market by Product (Coin & Currency Counter, Currency Sorter, Currency Detector, & Pen), Technology (Ultraviolet, Infrared, Magnetic, Watermark, & Microprint), Industry, End Device, and Geography - Global Forecast to 2020
The counterfeit money detection market is expected to reach USD 3.11 Billion by 2020, growing at a CAGR of 6.9% between 2015 and 2020. The growth of this market is driven by initiatives taken by various governments to implement the counterfeit money detectors to prevent the circulation of fake currency. On a global level, the growing number of fraudulent activities and circulation of fake currency across sectors such as retail, gaming, and banking are also the prime causes for the growth of this said market.
- Published: February 2016
- Price: $ 4950
- TOC Available:
-
Barrier Resins Market by Type (PVDC, EVOH, PEN), Application (Food & Beverage, Pharmaceutical & Medical, Cosmetics, Agriculture, Industrial), and Region (Asia-Pacific, North America, Europe, South America, Middle East & Africa) - Global Forecast to 2026
The barrier resins market size is projected to reach a market size of USD 16.6 billion by 2026, at a CAGR of 5.9 % during the forecasting period. The key players in the barrier resins market include LyondellBasell Industries (US), Kuraray Co Ltd. (Japan), Exxon Mobil Corporation (US), and The Dow Chemical Company (US).
- Published: August 2021
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Europe Pen Needles Market By Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-like Peptide-1 Therapy), Mode of Purchase (Over-the-counter Purchase, Online Purchase) - Forecast to 2031
Europe Pen Needles market, valued at US$0.66 billion in 2025, stood at US$0.72 billion in 2026 and is projected to advance at a resilient CAGR of 8.9% from 2026 to 2031, culminating in a forecasted valuation of US$1.10 billion by the end of the period. The Europe pen needles market is propelled by soaring rate of diabetes prevalence, growing numbers of older adults, high levels of obesity, augmented uptake of insulin and GLP-1 pens leading to increased per-patient needle usage.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
US Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-like Peptide-1 Therapy), Mode of Purchase (Over-the-counter Purchase, Online Purchase)- Forecast to 2031
The US pen needles market, valued at US$0.85 billion in 2025, stood at US$0.93 billion in 2026 and is projected to advance at a resilient CAGR of 10.4% from 2026 to 2031, culminating in a forecasted valuation of US$1.53 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-Like Peptide-1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase) - Global Forecast to 2030
The global pen needles market, valued at US$1.69B in 2023, is forecasted to grow at a 9.2% CAGR, reaching US$1.81B by 2024 and US$3.08B by 2030. The key factors driving the market growth of the pen needles market include the rising incidence of chronic diseases, favorable reimbursements in certain countries, and decreasing prices of insulin formulations. Factors that provide opportunities for market players include the growing preference for biosimilar drugs, emerging economies to offer high-growth potential, and rising healthcare expenditure on diabetes.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030
The global insulin delivery devices market, valued at US$32.6 billion in 2024, stood at US$35.3 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$ 52.7 billion by the end of the period. The insulin delivery devices market is experiencing steady growth, primarily due to the increasing number of individuals diagnosed with diabetes. The rising prevalence of type 1 diabetes, in particular, is driving the demand for insulin delivery devices, as patients with this condition rely on insulin to manage their blood glucose levels.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
